Synopsys Accelerates Chip Design with NVIDIA Grace Blackwell and AI to Speed Electronic Design Automation
Announcing Up to 30x Projected Performance Gains on the NVIDIA Grace Blackwell Platform to Speed Circuit Simulations for Next-Generation Semiconductors
News Highlights:
Today's GTC keynote featured Synopsys as part of the ecosystem with full-stack EDA suite acceleration across design, verification, and manufacturing on NVIDIA GPU and NVIDIA CUDA-X libraries.
Leveraging the NVIDIA GB200 Grace Blackwell Superchip, Synopsys PrimeSim is projected to accelerate circuit simulation by up to 30x.1
Leveraging the NVIDIA B200 Blackwell architecture, Synopsys Proteus is projected to accelerate computational lithography simulations by up to 20x.1
NVIDIA NIM inference microservices integration driving 2x faster time-to-information with generative AI-powered Synopsys.ai Copilot.2
Optimizing more than 15 Synopsys solutions for NVIDIA Grace CPU in 2025.
SUNNYVALE, Calif., March 18, 2025 /PRNewswire/ -- Synopsys Inc. (Nasdaq: SNPS) today announced the next phase of its work with NVIDIA to accelerate chip design up to 30x with the NVIDIA Grace Blackwell platform.
To achieve this speedup, Synopsys announced at the GTC global AI conference that it is using NVIDIA CUDA-X libraries to optimize its solutions for next-generation semiconductor development. The company is also expanding support for the NVIDIA Grace CPU architecture and enabling more than 15 Synopsys solutions in 2025.
"At GTC, we're unveiling the latest performance results observed across our leading portfolio when optimizing Synopsys solutions for the NVIDIA Blackwell platform to accelerate computationally-intensive chip design workflows," said Sassine Ghazi, president and CEO of Synopsys. "Synopsys technology is mission-critical to the productivity and capabilities of engineering teams from silicon to systems. By harnessing the performance of NVIDIA accelerated computing, we can help customers unlock new breakthroughs and deliver innovation even faster."
"Chip design is one of the most complex engineering challenges in human history," said Jensen Huang, founder and CEO of NVIDIA. "With NVIDIA Blackwell and CUDA-X, Synopsys is cutting simulation times from days to hours—advancing chip design to power the AI revolution."
Synopsys and NVIDIA are advancing a multi-year collaborative effort to accelerate electronic design automation (EDA) workloads. Synopsys is further applying NVIDIA accelerated compute architectures, including the NVIDIA GB200 Grace Blackwell Superchip, to achieve significant, projected runtime gains for workflows including circuit simulation, computational lithography, Technology Computer-Aided Design (TCAD), physical verification, and materials engineering. These accelerated workflows include:
Circuit Simulation: Synopsys PrimeSim™ SPICE simulation workloads are projected to achieve a 30x speed up utilizing the NVIDIA Grace Blackwell platform. Today, customers can achieve up to 15x speed up utilizing NVIDIA GH200 Superchips. NVIDIA accelerated computing architectures enable the simulation of challenging circuits to achieve signoff with SPICE-level accuracy, reducing runtimes from days to hours.
Computational Lithography: The production-proven choice for accelerating computational lithography for more than two decades, Synopsys Proteus™ provides optical proximity correction (OPC) software and inverse imaging technology (ILT) to resolve challenges at leading technology nodes. By leveraging NVIDIA technologies, Synopsys is delivering game-changing technology to advance this computationally-intensive manufacturing process. Today, Synopsys Proteus is optimized for NVIDIA H100 GPUs and integrated with the NVIDIA cuLitho library, achieving a 15x speed up of OPC. Leveraging the NVIDIA Blackwell platform, Synopsys Proteus is expected to accelerate computational lithography simulations by up to 20x.
TCAD Simulation: Early results applying GPU-enabled capabilities and NVIDIA CUDA-X libraries to the Synopsys Sentauras™ TCAD process and device simulation solution is projected to accelerate time to results up to 10x. This solution is currently under development and is expected to be available to customers later this year.
Materials Engineering: Synopsys QuantumATK® delivers atomic-scale modeling for semiconductor and materials research and development. Utilizing CUDA-X libraries on the NVIDIA Hopper architecture can accelerate time to results up to 100x, enabling customers to simulate and analyze a wide range of materials with greater efficiency.
Synopsys plans to continue enabling accelerated computing on NVIDIA platforms throughout its portfolio.
Advancing Synopsys Solutions with NVIDIA AI SoftwareSynopsys and NVDIA's efforts to accelerate chip design extend to speeding chip design with generative AI using NVIDIA NIM microservices:
Generative AI Software for Chip Design: Today, customers using Synopsys' Gen AI-powered knowledge assistant, Synopsys.ai Copilot, are realizing an average 2x productivity improvement compared to prior methods. The integration of NVIDIA NIM microservices is projected to enable an additional 2x speedup for even faster time to answers.2
Optimizing Synopsys EDA with Grace CPU
Additionally, Synopsys is enabling more than 15 solutions using the Grace CPU architecture for Synopsys EDA workloads spanning circuit simulation, physical verification, static timing analysis, and functional verification. The company plans to further increase support on the Grace CPU architecture in 2025.
Synopsys at GTC 2025Synopsys is demonstrating at GTC 2025 March 18th through 21st in booth #222 in the Design and Simulation Pavilion. The company is also presenting sessions on semiconductor manufacturing and materials engineering and AI-driven chip design. For more information about Synopsys' presence at GTC, visit https://www.synopsys.com/events/nvidia-gtc.html.
1 Compared to CPU-based models.2 Synopsys.ai Copilot knowledge assistance without NVIDIA NIM integration.
About SynopsysCatalyzing the era of pervasive intelligence, Synopsys, Inc. (Nasdaq: SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.
© 2025 Synopsys, Inc. All rights reserved. Synopsys, the Synopsys logo, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html. Other company or product names may be trademarks of their respective owners.
Forward-Looking StatementsThis press release contains forward-looking statements, including, but not limited to, statements regarding strategies related to products, technology and services and planned product releases and capabilities. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors that could affect Synopsys' results is included in filings we make with the SEC from time to time, including in the sections entitled "Risk Factors" in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The information provided herein is as of March 18, 2025. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.
Editorial ContactKelli WheelerSynopsys, Inc.corp-pr@synopsys.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-accelerates-chip-design-with-nvidia-grace-blackwell-and-ai-to-speed-electronic-design-automation-302404958.html
SOURCE Synopsys, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Nvidia's Stock and Business: How Did I Do With My 5-Year Predictions Made in 2020?
Co-founder and CEO Jensen Huang is still leading the company, as I predicted in 2020. Nvidia's GPUs are still the gold standard for artificial intelligence (AI) training, as I predicted in 2020. Nvidia stock has "solidly outperformed the market" -- an understatement --- as I predicted in 2020. 10 stocks we like better than Nvidia › In March 2020, I outlined where I thought tech giant Nvidia's business and stock would be in five years, or in March 2025. It's now a little past the five-year mark, so how did I do? Overall, I'd give myself a B or a B+. I was mostly correct in my business predictions and accurate about what investors care about the most, the stock price: "I feel very comfortable predicting that Nvidia stock will solidly outperform the market over the next half decade," I wrote. Indeed, from March 1, 2020 (when my five-year predictions article published) through March 1, 2025, Nvidia stock's total return was 1,760% -- nearly 15 times the S&P 500's return of 118%. In other words, Nvidia stock turned a $1,000 investment into a whopping $18,600 over this five-year period. (Nvidia stock's five-year return through the date of this writing, June 4, is a little lower, as the chart below shows. Shares are up since March 1; it's the change in the 2020 start date that slightly lowers their current five-year return.) Nvidia stock's fantastic performance has largely been driven by the incredible demand for the company's graphics processing units (GPUs) and related technology that enable artificial intelligence (AI) capabilities. Status: Correct. In March 2020, I wrote that "as long as [Huang] stays healthy, the odds seem in favor of his still being at Nvidia's helm in five years." For context, Jensen Huang, who co-founded the company in 1993, turned 62 in February, according to public records. Nvidia investors should certainly hope that Huang remains the company's leader for some time. As I wrote in June 2024: Nvidia is many years ahead of the competition in AI-enabling technology thanks to Huang's foresight. Starting more than a decade ago, he began to steadily use profits from Nvidia's once-core computer gaming business to position the company to be in the catbird seat when the "AI Age" truly arrived. Status: Correct. Here's part of what I wrote in the March 2020 article: Nvidia dominates the market for discrete graphics processing units (GPUs) -- the key component in graphics cards for desktop computer gaming. In the fourth quarter of 2019, the company controlled 68.9% of this market. Nvidia has increased its leadership position over the last five years. In the fourth quarter of 2024, it had an 82% share of the desktop discrete GPU market, compared with longtime rival Advanced Micro Devices' 17% share, according to Jon Peddie Research. Intel, which entered this market in 2022, had a 1% share. Growth in Nvidia's gaming market platform will be covered below. Status: Correct. In March 2020, I wrote: "In 2025, the gaming market should be much bigger [relative to 2020]." By all counts -- the number of global gamers, total computer gaming market revenue, and computer gaming PC revenue -- the computer gaming market has grown solidly over the last five years. And Nvidia has benefited nicely from this growth. In fiscal year 2020 (ended late January 2020), the company's gaming market platform generated revenue of $5.52 billion. In fiscal 2025 (ended in late January), this platform's revenue was $11.35 billion. This increase amounts to a compound annual growth rate (CAGR) of 15.5%. This is strong growth for such a huge market. It might not seem so only because Nvidia's data center market platform's growth has been phenomenal over this same period. In fiscal 2020, gaming was Nvidia's largest platform, accounting for 51% of its total revenue. In fiscal 2025, gaming was its second-largest platform behind data center, contributing about 9% of its total revenue. Status: Correct. In March 2020, I wrote: The company's GPU-based approach to accelerating computing is considered the gold standard for DL [deep learning, the dominant type of AI] training, the first step in the two-step DL process. [The second step is inferencing.] This statement is extremely likely to hold true in 2025, in my opinion. Since 2020, both AMD and Intel have launched GPUs for AI-powered data centers, but Nvidia's grip on this market -- which is growing like wildfire -- remains tight. IoT Analytics, a technology market research firm, estimates Nvidia had a 92% share of the data center GPU market in 2024. As an added plus, since 2020, Nvidia's GPUs have gone from having very little share of the AI inferencing chip market to having the largest chunk of this market. Inferencing is the running of an AI application. In fiscal 2020, Nvidia's data center platform's revenue was $2.98 billion. It skyrocketed to $115.2 billion in fiscal 2025, equating to about a 107% compound annual growth rate (CAGR). This amazing growth powered the data center to account for 88% of Nvidia's total revenue in fiscal 2025, up from 27% in fiscal 2020. Status: My timeline was too optimistic. In March 2020, I wrote: "In 2025, fully autonomous vehicles should be legal -- or very close to being so -- across the United States. Nvidia is well positioned to majorly profit from [this event]." I wouldn't say that fully autonomous vehicles are "very close" to being legal across the U.S. This event seems at least a few years away. But I continue to believe this watershed event will "turbocharge" Nvidia's growth thanks to its widely adopted AI-powered DRIVE platform. Status: Correct. In March 2020, I wrote: "Nvidia is incredibly innovative, so there seems a great chance that the company will introduce at least one major new technology that takes nearly everyone by surprise." Over the last five years, Nvidia has launched a good number of major new technologies that have likely taken most investors and Wall Street analysts by surprise. One example is its Omniverse platform, which launched in 2021. This is a simulation platform that enables the creation of virtual worlds and digital twins. It's been widely adopted by a broad industry range of large enterprise companies -- including Amazon, PepsiCo, and BMW Group -- for uses such as designing products and optimizing facility workflow. Status: Correct. Here's what I wrote in March 2020: It's impossible to predict a company's stock price in five years because so many unknowns ... can have a huge influence on the market in general. That said, given the projections made in this article, I feel very comfortable predicting that Nvidia stock will solidly outperform the market over the next half decade. Stay tuned. I'm planning on a predictions article similar to my 2020 one. Hint: It's going to be optimistic, as Nvidia's highly profitable strong revenue growth is far from over, in my opinion. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Beth McKenna has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Amazon, Intel, and Nvidia. The Motley Fool recommends Bayerische Motoren Werke Aktiengesellschaft and recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy. Nvidia's Stock and Business: How Did I Do With My 5-Year Predictions Made in 2020? was originally published by The Motley Fool
Business Insider
an hour ago
- Business Insider
Nvidia Stock Won't Make Millionaires From Here, Unless AI Demand Goes Parabolic
Nvidia (NVDA) stock is up 45% since April, now hovering around $140. That sounds like a win. But for retail investors hoping this will mint the next generation of millionaires, there's a catch: most of the good news is already priced in. Wall Street still loves Nvidia, but the higher it goes, the harder it becomes to justify buying more—unless something explosive happens in AI demand. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Broadcom Earnings Prove the AI Pie Is Real — and Growing Broadcom (AVGO) just reported Q2 results, beating expectations and raising guidance. The key number? A projected 60% growth in AI revenue this Fiscal year. That's massive. And even though AVGO dipped slightly after earnings, the broader message was bullish for the whole chip sector: AI demand isn't slowing. This supports Nvidia's entire bull case. Nvidia sells the chips that train and deploy AI models. If cloud giants like Amazon (AMZN), Microsoft (MSFT), and Alphabet (GOOGL) are still pouring billions into AI infrastructure, Nvidia will remain the backbone of that effort. Why AI Growth Needs to Go Exponential to Justify Nvidia's Price Here's the hard truth: even a great company can become a bad investment at the wrong price. Nvidia's market cap now reflects a future where AI continues to expand indefinitely. That means AI must expand into new industries like healthcare, robotics, and manufacturing. Edge computing needs to explode. AI hardware refresh cycles need to shorten. Governments and enterprises need to ramp up AI R&D. If these things don't accelerate at scale, Nvidia risks running ahead of its fundamentals. That's why the stock may not create millionaires from here—unless we get another generational leap in spending. Valuation Is Now the Enemy of Asymmetry Back in 2022 and even 2023, Nvidia was still misunderstood. You could buy shares and realistically expect a 2x or 3x return. Today? That asymmetry is gone. With a forward P/E near 50 and trillions in market cap, the company needs to beat high expectations every quarter just to tread water. This makes it hard for small investors to win big. You're not catching a rocket ship at liftoff. You're hopping on after it's halfway to orbit. Sure, it might keep climbing. But the risk/reward has fundamentally changed. A Macro Setup That's Starting to Tighten Nvidia's growth narrative also faces macro threats. U.S.-China chip tensions limit sales of high-end GPUs abroad. A strong dollar may weigh on foreign demand. Rates remain high, tightening funding for startups and AI moonshots. And then there's the bond market. If Treasury yields spike again, tech multiples could compress. Nvidia is particularly sensitive to these macro ripples, which could pull the stock down even if earnings stay solid. Great Businesses Don't Guarantee Great Returns Investors need to ask: Is Nvidia the next Apple or the next Cisco? Apple rode the smartphone wave for over a decade, compounding steadily. Cisco, during the dot-com boom, also led a tech revolution. But anyone who bought Cisco at the peak in 2000 had to wait nearly 20 years to break even. The question isn't just 'how good is Nvidia?' It's 'how much of that greatness is already priced in?' Nvidia Is a Winner, But That Doesn't Make You One Nvidia's fundamentals are strong. Its technology is best-in-class. And AI isn't a fad. But the dream of getting rich from here may be just that—a dream. Unless AI spending enters a new phase of hyper-acceleration, Nvidia may deliver solid, steady gains—not life-changing ones. And that's a distinction every long-term investor needs to understand before chasing another breakout. Is Nvidia a Buy, Sell, or Hold? TipRanks shows a Strong Buy consensus on NVDA, based on 35 Buys, four Holds, and one Sell rating. The average NVDA target price is $172.36. That implies a 23% upside, but in this kind of rally, forward gains don't come easy. You need acceleration—not just growth, but growth of the growth.
Yahoo
2 hours ago
- Yahoo
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus
